| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |